on 1 Apr 2025
Last Applicant/ Owned by
Bio-Thera Solutions, Ltd.
A6-5FL., 11 Kaiyuan Rd., Science City, High-tech IndustrialDevelopment Zone Guangzhou, Guangdong,
CN
Serial Number
2205113 filed on 19th Aug 2022
Correspondent Address
NELLIGAN O'BRIEN PAYNE LLP
300-50 O'CONNOR STREETOTTAWA
ONTARIO
CA
K1P6L2
Trademark usage description
pharmaceutical preparations for the treatment of cancer; injectable pharmaceutical preparations for the treatment of cancer; medicines for the treatme Read MoreVienna Information
24 . 17 . 1
Punctuation marksSignes de ponctuation
24 . 17 . 2
DotsPoints
25 . 7 . 1
Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés
25 . 7 . 6
Surfaces or backgrounds covered with circles or ellipsesSurfaces ou fonds couverts de cercles ou d'ellipses
25 . 7 . 7
Surfaces or backgrounds covered with dotsSurfaces ou fonds couverts de points
26 . 1 . 1
CirclesCercles
26 . 1 . 6
Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant
26 . 1 . 24
Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée
26 . 11 . 3
More than two lines or two bandsPlus de deux lignes ou de deux bandes
26 . 11 . 8
Horizontal lines or bandsLignes ou bandes horizontales
26 . 11 . 9
Oblique lines or bandsLignes ou bandes obliques
26 . 11 . 10
Straight lines or bandsLignes ou bandes droites
26 . 11 . 14
Dotted lines or bandsLignes ou bandes pointillées
11
2205113
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 27 on 1st Apr 2025 | Approval Notice Sent |
Submitted for opposition 26 on 1st Apr 2025 | Approved |
Submitted for opposition 22 on 24th Mar 2025 | Search Recorded |
Submitted for opposition 287 on 25th Aug 2022 | Pre-Assessment Letter Sent |
Submitted for opposition 30 on 19th Aug 2022 | Filed |
Submitted for opposition 1 on 19th Aug 2022 | Created |
Submitted for opposition 31 on 19th Aug 2022 | Formalized |